Hanafy et al.’s [6] findings suggest that mints provide a substantial basis for future research into Alzheimer’s disease treatment because of the total phenolic content, antioxidant capacity, acetylcholinesterase (AChE) and histone deacetylase (HDAC) inhibition activities. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.